USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark MEDUSA was filed as Word mark on 02/12/1997 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/29/1999.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 75240725 |
| Register number | 2256280 |
| Application date | February 12, 1997 |
| Publication date | October 27, 1998 |
| Entry date | June 29, 1999 |
Trademark owner
Parc-Club du Moulin a Vent
69693 VENISSIEUX CEDEX
FR
69693 VENISSIEUX CEDEX
FR
Trademark representatives
goods and services
1
chemicals, namely, particles made of polyaminoacids for general manufacturing use; chemicals, namely, particles made of polyaminoacids for use in conveying and/or delivering medicinal, nutritional, phytosanitary and/or chemical active ingredients and/or active principles into or onto living organisms including humans and animals; chemicals, namely, particles made of polyaminoacids for use as chemical active ingredients and/or active principles in nutritional, herbicidal, pesticidal, insecticidal, and fungicidal preparations, to convey or deliver the same into or onto living organisms including humans and animals; chemicals, namely, particles of polyaminoacids for use in conveying and/or delivering cosmetic active ingredients and/or active principles into or onto living organisms including humans and animals, sold only to manufacturers of cosmetics; chemicals, namely, particles made of polyaminoacids for use as cosmetic active ingredients and/or active principles to convey and/or deliver the same into or onto living organisms including humans and animals, sold only to manufacturers of cosmetics
5
pharmaceuticals, namely, particles made of polyaminoacids for use as medicinal active ingredients and/or active principles to convey and/or deliver the same into or onto living organisms including humans and animals, for the treatment of bacterial infections; pharmaceuticals, namely, particles of polyaminoacids, for use as medicinal active ingredients and/or active principles, namely, nutritional protein supplements, vitamins, nutritional amino acid supplements, nutritional trace element supplements, synthetic peptides to enhance fertility, diagnostic peptides for clinical medical use, hemoglobin, interferons and interleukins for use in treating viral and autoimmune diseases, DNA sequence producing intercellular antigens for an immunofluorescent assay for clinical medical use, pharmaceutical preparations and substances for the treatment of bacterial infections, erythropoietin and human factor IX for the treatment of chronic anemia, insulin, growth hormones, clinical medical diagnostic preparations, heparin solutions for blood testing, nucleic acids in the nature of oligonucleotides of RNA and/or DNA for gene therapy and vaccines, all to convey and/or deliver the same into or onto living organisms including humans and animals
ID: 1375240725